ZA882388B - Chalcone derivatives and their preparation and use - Google Patents

Chalcone derivatives and their preparation and use

Info

Publication number
ZA882388B
ZA882388B ZA882388A ZA882388A ZA882388B ZA 882388 B ZA882388 B ZA 882388B ZA 882388 A ZA882388 A ZA 882388A ZA 882388 A ZA882388 A ZA 882388A ZA 882388 B ZA882388 B ZA 882388B
Authority
ZA
South Africa
Prior art keywords
chalcone derivatives
preparation
inhibit
reported
agents
Prior art date
Application number
ZA882388A
Other languages
English (en)
Inventor
L. Edwards Michael
M. Stemerick David
P. Sunkara Sai
Original Assignee
Merrell Dow Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc. filed Critical Merrell Dow Pharmaceuticals Inc.
Publication of ZA882388B publication Critical patent/ZA882388B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/45—Monoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Saccharide Compounds (AREA)
ZA882388A 1987-04-09 1988-04-05 Chalcone derivatives and their preparation and use ZA882388B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3621487A 1987-04-09 1987-04-09

Publications (1)

Publication Number Publication Date
ZA882388B true ZA882388B (en) 1988-09-22

Family

ID=21887305

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882388A ZA882388B (en) 1987-04-09 1988-04-05 Chalcone derivatives and their preparation and use

Country Status (10)

Country Link
EP (1) EP0287901B1 (de)
KR (1) KR880012529A (de)
AT (1) ATE55108T1 (de)
AU (1) AU608821B2 (de)
DE (1) DE3860376D1 (de)
ES (1) ES2016865B3 (de)
GR (1) GR3000689T3 (de)
IE (1) IE60734B1 (de)
PH (1) PH24634A (de)
ZA (1) ZA882388B (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54152091A (en) * 1978-05-22 1979-11-29 Fuji Photo Film Co Ltd Photopolymerizable composition
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
CA1168659A (fr) * 1980-08-06 1984-06-05 Gerard Lang Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant

Also Published As

Publication number Publication date
IE881076L (en) 1988-10-09
AU1416588A (en) 1988-10-13
DE3860376D1 (de) 1990-09-06
GR3000689T3 (en) 1991-09-27
PH24634A (en) 1990-08-17
ATE55108T1 (de) 1990-08-15
AU608821B2 (en) 1991-04-18
EP0287901B1 (de) 1990-08-01
EP0287901A1 (de) 1988-10-26
ES2016865B3 (es) 1990-12-01
KR880012529A (ko) 1988-11-28
IE60734B1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
EP0288794A3 (en) Controlling the growth of tumor tissue with chalcone derivatives
AU1416688A (en) Method of treating multiple sclerosis with chalcone derivatives
EP0348353A3 (en) The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases
CA2098849A1 (en) Control of gene expression by ionizing radiation
DE3860043D1 (de) Verwendung von biertreberextrakt zur herstellung von medizinischen und kosmetischen zubereitungen.
ES2051882T3 (es) Composicion que comprende implantes oculares biodegradables.
CA2068281A1 (en) Tumor treatment
ATE345092T1 (de) Apparat zur therapeutischen elektromagnetischen strahlen therapie von der haut
FI852626A0 (fi) Menetelmä ihmisen tuumorinekroositekijän valmistamiseksi ja sitä koodaava DNA
EP0787802A3 (de)
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
FI911986A0 (fi) Farmaceutiska foereningar.
ATE84721T1 (de) Physiologisch wirksame produkte, verfahren zur herstellung und zusammensetzung.
AU2894389A (en) Novel preparation and method of use thereof
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
EP0253146A3 (de) Die Verwendung von D-fenfluramin zur Herstellung von Arzneimitteln, zur Behandlung von Depressionen
PH24634A (en) Chalcone derivatives and composition
ATE59780T1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
ES8205190A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10-14-hexadecapentaenoico.
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
GR3034661T3 (en) Use of Selegiline in vetenary medicine.
AU6592890A (en) Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
EP0312132A3 (en) Veterinary and human medical remedy having an antiviral and antitumorous activity, containing 2,6-diamino-3-phenyl-azo-pyridine
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus